Monte Carlo study of organ doses and related secondary cancer risk estimations for patients undergoing prostate radiotherapy: Algerian population-based study

被引:0
|
作者
Alem-Bezoubiri, Asma [1 ]
Bezoubiri, Fethi [2 ]
Speiser, Michael [3 ]
Suleiman, Suleiman Ameir [4 ]
Donya, Hossam [5 ,6 ]
Chami, Ahmed Chafik [7 ]
机构
[1] Algiers Nucl Res Ctr CRNA, Radiol & Atom Phys Dept, Div Phys, 02 Blvd Frantz Fanon,BP 399 Alger-RP, Algiers 16000, Algeria
[2] Atom Energy Commiss COMENA, 02,Blvd Frantz FanonAlger, Algiers, Algeria
[3] Englewood Hosp & Med Ctr, Englewood, NJ USA
[4] Tanzania Atom Energy Commiss, Radiat Control Directorate, POB 1585, Dodoma, Tanzania
[5] King Abdulaziz Univ, Fac Sci, Dept Phys, Jeddah 21589, Saudi Arabia
[6] Menoufia Univ, Fac Sci, Dept Phys, Shibin Al Kawm 32511, Egypt
[7] Univ Sci & Technol Houari Boumediene USTHB, Fac Phys, BP 32 El Alia,Bab Ezzouar, Algiers, Algeria
关键词
OF-FIELD ORGAN; NEUTRON-SPECTRA; MV; ACCELERATOR; SIMULATION; EQUIVALENT; DOSIMETRY; THERAPY; LINACS; IMRT;
D O I
10.1016/j.apradiso.2024.111595
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The present study aimed to assess organ doses and the associated cancer risks related to secondary radiation (photons and neutrons) exposure during 3D Conformational Radiotherapy (3D-CRT) for patients with prostate cancer in Algeria. To this purpose, a detailed geometric Monte Carlo (MC) modeling of the LINAC, combined with a hybrid whole-body phantom was carried out. The secondary radiation doses were calculated in patient's organs, both within and outside the field. The obtained doses were used to estimate the Lifetime Attributable Risks (LARs) for cancer incidence for out of field organs, using the Biological Effects of Ionizing Radiation VII (BEIR VII) risk model, considering the exposure age range according to the age of the treated patients in Algeria. The survival information and baseline cancer risks were based on relevant statistics for the Algerian population. The results revealed that secondary radiation equivalent doses mostly depend on the distance of organs from the treated volume. The highest and lowest equivalent doses of 5.77 mSv/Gy and 0.24 mSv/Gy were recorded in the small intestine and ocular lens, respectively. LARs decreased as the age of exposure increased, with the highest estimated value per 100,000 individuals identified at a 35-year exposure age (88 for the colon and 15 for the intestine). Conversely, the lowest risks were found at 70 years of age, specifically in rib bone and leg bone with value of (0). The current research could contribute to establishing a database concerning the incidence of secondary cancers induced by radiotherapy during 3D-CRT for prostate cancer in Algeria.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Monte Carlo study on the secondary cancer risk estimations for patients undergoing prostate radiotherapy: A humanoid phantom study
    Ghasemi-Jangjoo, Amir
    Ghiasi, Hosein
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2020, 25 (02) : 187 - 192
  • [2] A Population-Based Study of Secondary Prostate Cancer Risk after Radiotherapy in Male Patients with Rectal Cancer: A Retrospective Cohort Study
    Chuang, Jen-Pin
    Lee, Yen-Chien
    Lee, Jenq-Chang
    Lu, Chin-Li
    Li, Chung-Yi
    MEDICINA-LITHUANIA, 2019, 55 (04):
  • [3] Calculation of organ doses from breast cancer radiotherapy: a Monte Carlo study
    Berris, T.
    Mazonakis, M.
    Stratakis, J.
    Tzedakis, A.
    Fasoulaki, A.
    Damilakis, J.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2013, 14 (01): : 133 - 146
  • [4] SECONDARY MALIGNANCIES AFTER RADIOTHERAPY FOR PROSTATE CANCER: A POPULATION-BASED STUDY
    Barcena, Quintana P.
    Aprikian, A.
    Dragomir, A.
    VALUE IN HEALTH, 2022, 25 (12) : S45 - S45
  • [5] RADIOTHERAPY AND SURVIVAL IN PROSTATE CANCER PATIENTS: A POPULATION-BASED STUDY
    Zhou, Esther H.
    Ellis, Rodney T.
    Cherullo, Edward
    Colussi, Valdir
    Xu, Fang
    Chen, Wei-Dong
    Gupta, Sanjay
    Whalen, Christopher C.
    Bodner, Donald
    Resnick, Martin I.
    Rimm, Alfred A.
    Koroukian, Siran M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (01): : 15 - 23
  • [6] Quality of care indicators and their related outcomes: A population-based study in prostate cancer patients treated with radiotherapy
    Webber, Colleen
    Brundage, Michael D.
    Siemens, David Robert
    Groome, Patti A.
    RADIOTHERAPY AND ONCOLOGY, 2013, 107 (03) : 358 - 365
  • [7] Does radiotherapy increase the risk of colorectal cancer among prostate cancer patients? A large population-based study
    Ho, Chung-Han
    Cheng, Kuo-Chen
    Chao, Chien-Ming
    Lai, Chih-Cheng
    Chiang, Shyh-Ren
    Chen, Chin-Ming
    Liao, Kuang-Ming
    Wang, Jhi-Joung
    Lee, Po-Huang
    Hung, Chao-Ming
    Tai, Chi-Ming
    Chiu, Chong-Chi
    JOURNAL OF CANCER, 2020, 11 (21): : 6204 - 6212
  • [8] Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT
    Alem-Bezoubiri, Asma
    Ameir Suleiman, Suleiman
    Behidj, Ikram
    Mazrou, Hakim
    Chami, Ahmed Chafik
    APPLIED RADIATION AND ISOTOPES, 2022, 180
  • [9] Aggravation of Hemorrhoids in Patients With Cervical Cancer Undergoing Radiotherapy: A Nationwide Population-based Study
    Seo, Incheol
    Jang, Hyunsoo
    IN VIVO, 2021, 35 (04): : 2357 - 2361
  • [10] Risk of Device Malfunction in Cancer Patients with Implantable Cardiac Device Undergoing Radiotherapy: A Population-Based Cohort Study
    Zaremba, Tomas
    Jakobsen, Annette Ross
    Sogaard, Mette
    Thogersen, Anna Margrethe
    Johansen, Martin Berg
    Madsen, Laerke Bruun
    Riahi, Sam
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2015, 38 (03): : 343 - 356